Related references
Note: Only part of the references are listed.Low-dose Antihypertensive Treatment with a Thiazide Diuretic Is Not Diabetogenic
GÖRAN BERGLUND et al.
ACTA MEDICA SCANDINAVICA (2010)
Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004
Heli Ghandehari et al.
AMERICAN HEART JOURNAL (2008)
Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2008)
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-blood pressure lowering arm and the relative influence of antihypertensive medication
Ajay K. Gupta et al.
DIABETES CARE (2008)
Vitamins E and C in the Prevention of Cardiovascular Disease in Men The Physicians' Health Study II Randomized Controlled Trial
Howard D. Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Paget's disease of the mandible
Mayank B. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cardiovascular protection using beta-blockers - A critical review of the evidence
Sripal Bangalore et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
The vasoldilatory beta-blockers
Michala E. Pedersen et al.
CURRENT HYPERTENSION REPORTS (2007)
Body weight changes with β-blocker use:: Results from GEMINI
Franz H. Messerli et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Effects of transmural pressure and wall shear stress on LDL accumulation in the arterial wall: a numerical study using a multilayered model
Nanfeng Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension
Andreas J. Flammer et al.
JOURNAL OF HYPERTENSION (2007)
Heart disease and stroke statistics - 2007 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2007)
Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study - A threshold relationship?
Phyo K. Myint et al.
STROKE (2007)
Antioxidant activity of carvedilol in cardiovascular disease
Paresh Dandona et al.
JOURNAL OF HYPERTENSION (2007)
C-reactive protein: a nontraditional serum marker of cardiovascular risk
Sarah D. de Ferranti et al.
CARDIOVASCULAR PATHOLOGY (2007)
Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: The Yestono study
Andre C. Schmidt et al.
CLINICAL DRUG INVESTIGATION (2007)
Anti hypertensive treatment with beta-blockers and the spectrum of glycaemic control
P. A. Sarafidis et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2006)
Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension
P. Peter et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Glucose metabolism in patients with essential hypertension
J García-Puig et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients
T Celik et al.
JOURNAL OF HYPERTENSION (2006)
Dyslipidemia and the risk of incident hypertension in men
RO Halperin et al.
HYPERTENSION (2006)
The cardiometabolic syndrome as a cardiovascular risk factor
G Govindarajan et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Optimizing treatment of diabetes and cardiovascular disease with combined α,β-blockade
DSH Bell
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes:: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)
PS Sever et al.
DIABETES CARE (2005)
Association of hemoglobin A1c with cardiovascular disease and mortality in adults:: The European prospective investigation into cancer in Norfolk
KT Khaw et al.
ANNALS OF INTERNAL MEDICINE (2004)
Expert consensus document on β-adrenergic receptor blockers
J López-Sendón et al.
EUROPEAN HEART JOURNAL (2004)
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial
GL Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Glycemic control from 1988 to 2000 among U.S adults diagnosed with type 2 diabetes - A preliminary report
CE Koro et al.
DIABETES CARE (2004)
Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes
S Jacob et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2004)
β-blockers in hypertension:: Is carvedilol different?
FH Messerli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
CJ Pepine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Vasodilating beta-adrenoceptor blockers as cardiovascular therapeutics
N Toda
PHARMACOLOGY & THERAPEUTICS (2003)
β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
DT Ko et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Carvedilol decreases elevated oxidative stress in human failing myocardium
K Nakamura et al.
CIRCULATION (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Residual lifetime risk for developing hypertension in middle-aged women and men - The Framingham Heart Study
RS Vasan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Oxidized LDL and HDL: antagonists in atherothrombosis
A Mertens et al.
FASEB JOURNAL (2001)
Nebivolol reverses endothelial dysfunction in essential hypertension - A randomized, double-blind, crossover study
N Tzemos et al.
CIRCULATION (2001)
The effects of bisoprolol, a selective β1-blocker, on glucose metabolism by long-term administration in essential hypertension
A Owada et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2001)
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure
N Suskin et al.
EUROPEAN HEART JOURNAL (2000)
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
TW Gress et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
